亚太药物输送设备市场 – 行业趋势及 2031 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

亚太药物输送设备市场 – 行业趋势及 2031 年预测

  • Medical Devices
  • Published Report
  • Aug 2024
  • Asia-Pacific
  • 350 页面
  • 桌子數: 381
  • 图号: 30

Asia Pacific Apac Drug Delivery Devices Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2024 –2031
Diagram Market Size (Base Year)
USD 320.82 Billion
Diagram Market Size (Forecast Year)
USD 669.66 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • F. Hoffmann
  • La Roche
  • Mylan N.V.
  • Teva Pharmaceutical Industries
  • Sanofi

>亚太药物输送设备市场,按产品类型(口服药物输送注射药物输送、局部药物输送、眼科药物输送、鼻腔药物输送、肺部药物输送透粘膜药物输送和植入式药物输送)、最终用户(医院、家庭医疗保健、诊所、社区医疗保健等)、分销渠道(直接招标、医院药房、药店和网上药房)划分——行业趋势和预测到 2031 年。

亚太药物输送设备市场

亚太药物输送设备市场分析及规模

亚太地区药物输送设备市场正在经历显著增长,这得益于慢性病和非慢性病患病率的上升、生物药物设备开发的增长以及诊断和治疗意识的提高。该市场的特点是,有大量参与者提供各种诊断设备,以满足该地区医疗保健提供者的多样化需求。

Data Bridge Market Research分析,亚太地区药物输送设备市场在2024年至2031年的预测期内以9.9%的复合年增长率增长,预计到2031年将从2023年的3208.2亿美元增至6696.6亿美元。

报告指标

细节

预测期

2024 至 2031 年

基准年

2023

历史性的一年

2022(可定制 2016-2021)

定量单位

收入(十亿美元)

涵盖的领域

产品类型(口服给药、注射给药、局部给药、眼科给药、鼻腔给药、肺部给药、透粘膜给药和植入式给药)、最终用户(医院、家庭医疗保健、诊所、社区医疗保健和其他)、分销渠道(直接招标、医院药房、药店和网上药店)

覆盖国家

日本、中国、韩国、印度、新加坡、泰国、印度尼西亚、马来西亚、菲律宾、澳大利亚和亚太地区其他地区

涵盖的市场参与者

强生服务公司、诺华公司、罗氏公司、拜耳公司、辉瑞公司、3M、艾伯维公司、安进公司、BD、Elcam Medical、Gerresheimer AG、葛兰素史克公司、Insulet Corporation、Medmix、默克公司、OraSure Technologies Inc.、赛诺菲、SMC Ltd. 和 West Pharmaceutical Services Inc. 等

市场定义

药物输送设备是一种医疗设备,旨在以可控和有针对性的方式将药物输送到人体,从而提高药物的疗效、安全性和患者依从性。这些设备可以是外部的,例如吸入器、注射器和泵,也可以是内部的,例如植入式设备,用于管理各种药物,包括小分子、生物制剂和疫苗。它们可以改变药物的释放速率、生物利用度和吸收率,并为患者和医疗保健提供者提供实时监控和反馈。药物输送设备在优化治疗结果和改善各种疾病和病症(包括慢性病、传染病和癌症)患者的生活质量方面发挥着至关重要的作用。

亚太地区药物输送设备市场动态

本节旨在了解市场驱动因素、优势、机遇、限制和挑战。以下内容将详细讨论所有这些内容:

驱动程序

  • 慢性病和非慢性病患病率上升

心血管疾病 (CVD)、哮喘、癌症、神经系统疾病、中风、糖尿病和呼吸系统疾病等疾病和病症的患病率在一段时间内显著增加。下面提到的是一些与某些慢性疾病相关的重要统计数据。慢性和非慢性疾病患病率的上升显著影响了药物输送设备市场的增长。糖尿病、心血管疾病和呼吸系统疾病等慢性疾病正变得越来越普遍,需要制定需要高效可靠的药物输送设备方法的长期治疗计划。

  • 生物药物设备开发的增长

生物制剂被认为是医药市场增长最快的领域之一。随着参与者的加入,品牌药和仿制药的生物制剂的开发和制造竞争日益激烈。生物制剂通常通过手臂、腿部或腹部注射给药。例如,Cimzia、Cosentyx、Enbrel 和 Humira 等。

机会

  • 自我给药设备的接受度不断提高

患者自行用药预计将为专注于开发创新和新型设备的药物输送企业提供巨大的增长机会。造成这种情况的主要因素是老年人口的增长,因为老年人口构成了家庭护理药物输送设备的庞大消费者群体。制药公司正专注于开发患者友好型疗法和自行用药的药物设备组合产品。随着自行用药越来越被接受,对特定应用的注射、吸入、外用和透皮药物产品的需求也在增加。

克制/挑战

  • 药物输送系统的副作用

药物输送系统的不良反应会导致患者依从性下降,从而导致对设备的需求下降。这可能会对设备制造商的销售和收入产生负面影响。副作用可能会引起对患者安全的担忧,导致监管机构加强审查和监管。这可能会导致产品发布延迟、额外的测试要求和设备制造商的成本增加。此外,副作用可能会导致患者排斥设备,从而导致对设备的需求下降。这对于需要长期使用的设备(例如可植入设备)来说尤其成问题。

最新动态

  • 2023 年 8 月,强生服务公司旗下的杨森制药公司向美国食品药品管理局 (FDA) 提交了补充生物制品许可申请 (sBLA),寻求批准 DARZALEX 与 Kyprolis 和地塞米松联合用于治疗复发/难治性多发性骨髓瘤。如果获得批准,这将增加公司的产品组合和收入来源
  • 2020 年 1 月,强生服务公司旗下的杨森制药公司宣布,欧盟委员会已批准其销售 Erleada,该药物与雄激素剥夺疗法 (ADT) 联合用于治疗转移性激素敏感性前列腺癌 (mHSPC)。这将增加其市场份额,从而进一步增加收入
  • 2020 年 12 月,强生服务公司旗下杨森制药宣布 SPRAVATO 鼻喷雾剂获得欧盟批准,这将增强其产品组合,从而进一步增加收入

亚太药物输送设备市场范围

根据产品类型、最终用户和分销渠道,亚太地区药物输送设备市场可分为三个显著的细分市场。细分市场之间的增长情况有助于您分析利基市场的增长空间和进入市场的策略,并确定您的核心应用领域和目标市场的差异。

产品类型

  • 口服药物输送
  • 注射药物输送
  • 局部给药
  • 眼科药物输送
  • 鼻腔给药
  • 肺部药物输送
  • 经粘膜给药
  • 植入式药物输送

根据产品类型,亚太地区药物输送装置市场分为注射药物输送制剂、注射药物输送、局部药物输送、眼科药物输送、鼻腔药物输送、肺部药物输送、透粘膜药物输送和植入式药物输送。

最终用户

  • 医院
  • 家庭医疗保健
  • 诊所
  • 社区医疗保健
  • 其他的

根据最终用户,亚太地区药物输送设备市场分为医院、家庭医疗保健、诊所、社区医疗保健和其他。

分销渠道

  • 直接招标
  • 医院药房
  • 药店
  • 网上药店

根据分销渠道,亚太地区药物输送设备市场分为直接招标、医院药房、药店和网上药房。

亚太药物输送设备市场区域分析/见解

对亚太地区药物输送设备市场进行分析,并根据上述产品类型、最终用户和分销渠道提供市场规模洞察和趋势。

本市场报告涵盖的国家包括日本、中国、韩国、印度、新加坡、泰国、印度尼西亚、马来西亚、菲律宾、澳大利亚和亚太地区其他地区。

由于中国医疗保健行业发展迅速、对医疗技术创新的大量投资以及庞大且日益富裕的人口推动着对先进医疗保健解决方案的需求,中国有望在亚太市场占据主导地位。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测各个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。  

竞争格局和亚太药物输送设备市场份额分析

根据产品类型、最终用户和分销渠道,亚太地区药物输送设备市场分为三个显著的部分。

亚太药物输送设备市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对亚太药物输送设备市场的关注有关。

亚太地区药物输送设备市场的一些主要参与者包括强生服务公司、诺华公司、罗氏有限公司、拜耳公司、辉瑞公司、3M、艾伯维公司、安进公司、BD、Elcam Medical、Gerresheimer AG、葛兰素史克公司、Insulet Corporation、Medmix、默克公司、OraSure Technologies Inc.、赛诺菲、SMC 有限公司和 West Pharmaceutical Services Inc. 等。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET END USER COVERAGE GRID

2.8 PRODUCT TYPE LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PORTERS FIVE FORCES

4.2 PESTEL ANALYSIS

5 REGULATORY FRAMEWORK

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 RISING PREVALENCE OF CHRONIC DISEASE AND NON-CHRONIC DISEASE

6.1.2 GROWTH IN THE DEVELOPMENT OF BIOLOGICS DRUGS DEVICES

6.1.3 INCREASING AWARENESS ABOUT DIAGNOSIS AND TREATMENT

6.1.4 INCREASED FOCUS ON PERSONALIZED MEDICINE AND DEVICES

6.2 RESTRAINTS

6.2.1 RISK OF NEEDLE-STICK INJURIES AND SIDE EFFECTS

6.2.2 HIGH COSTS OF INJECTABLE DRUGS

6.2.3 STRINGENT REGULATORY SCENARIO

6.3 OPPORTUNITIES

6.3.1 RISING ACCEPTANCE OF SELF-ADMINISTERING DRUG DEVICES

6.3.2 RISING DEMAND FOR BIOSIMILAR AND GENERIC DRUGS

6.3.3 THERAPEUTIC ADVANCEMENTS IN THE FIELD OF DRUG DELIVERY

6.4 CHALLENGES

6.4.1 SIDE EFFECTS OF DRUG DELIVERY SYSTEMS

6.4.2 INCREASE IN THE NUMBER OF ALTERNATIVES OF DRUG DELIVERY

7 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE

7.1 OVERVIEW

7.2 ORAL DRUG DELIVERY

7.2.1 SOLID ORAL DRUGS

7.2.1.1 TABLETS

7.2.1.2 CAPSULES

7.2.1.3 PILLS

7.2.1.4 POWDERS

7.2.2 LIQUID ORAL DRUGS

7.2.2.1 SYRUPS

7.2.2.2 SOLUTIONS

7.2.3 SEMI SOLID ORAL DRUGS

7.2.3.1 GELS

7.2.3.2 EMULSIONS

7.2.3.3 ELIXIRS

7.3 INJECTABLE DRUG DELIVERY

7.3.1 INJECTABLE DRUG DELIVERY FORMULATIONS

7.3.1.1 CONVENTIONAL DRUG DELIVERY FORMULATIONS

7.3.1.2 NOVEL DRUG DELIVERY FORMULATIONS

7.3.1.3 LONG ACTING INJECTION FORMULATIONS

7.3.2 INJECTABLE DRUG DELIVERY DEVICES

7.3.2.1 CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES

7.3.2.1.1 BY MATERIAL

7.3.2.1.1.1 GLASS

7.3.2.1.1.2 PLASTIC

7.3.2.1.2 BY PRODUCT TYPE

7.3.2.1.2.1 FILLABLE

7.3.2.1.2.2 PRE-FILLED

7.3.2.1.3 BY USABILITY

7.3.2.1.3.1 REUSABLE SYRINGES

7.3.2.1.3.2 DISPOSABLE SYRINGES

7.3.2.2 SELF INJECTION DRUG DELIVERY DEVICES

7.3.2.2.1 NEEDLE FREE INJECTORS

7.3.2.2.2 WEARABLE INJECTORS

7.3.2.2.3 PEN INJECTOR

7.3.2.2.4 AUTO INJECTORS

7.3.2.2.5 OTHERS

7.4 TOPICAL DRUG DELIVERY

7.4.1 TRANSDERMAL DRUG DELIVERY FORMULATIONS

7.4.1.1 SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS

7.4.1.1.1 OINTMENTS

7.4.1.1.2 CREAMS

7.4.1.1.3 LOTIONS

7.4.1.1.4 GELS

7.4.1.1.5 PASTES

7.4.1.2 LIQUID TOPICAL DRUG DELIVERY FORMULATIONS

7.4.1.2.1 SUSPENSIONS

7.4.1.2.2 SOLUTIONS

7.4.1.3 SOLID TOPICAL DRUG DELIVERY FORMULATIONS

7.4.1.3.1 POWDER

7.4.1.3.2 SUPPOSITORS

7.5 OPHTHALMIC DRUG DELIVERY

7.5.1 OCCULAR DRUG DELIVERY FORMULATIONS

7.5.1.1 LIQUID OCCULAR DRUG DELIVERY FORMULATIONS

7.5.1.1.1 SOLUTIONS

7.5.1.1.2 SUSPENSIONS

7.5.1.2 SEMI SOLID OCCULAR DRUG DELIVERY FORMULATIONS

7.5.1.2.1 GELS

7.5.1.2.2 OINTMENTS

7.5.2 OCCULAR DRUG DELIVERY DEVICES

7.6 NASAL DRUG DELIVERY

7.6.1 NASAL DROPS

7.6.2 NASAL SPRAYS

7.6.3 NASAL POWDERS

7.6.4 NASAL GELS

7.7 PULMONARY DRUG DELIVERY

7.7.1 METERED DOSE INHALERS (MDI)

7.7.2 DRY POWDER INHALERS (DPI)

7.7.3 NEBULIZERS

7.7.3.1 JET NEBULIZERS

7.7.3.2 ULTRASONIC NEBULIZERS

7.7.3.3 SOFT MIST NEBULIZERS

7.8 TRANSMUCOSAL DRUG DELIVERY

7.8.1 ORAL TRANSMUCOSAL DRUG DELIVERY

7.8.1.1 BUCCAL DRUG DELIVERY

7.8.1.2 SUBLINGUAL DRUG DELIVERY

7.8.2 OTHER TRANSMUCOSAL DRUG DELIVERY

7.8.2.1 RECTAL TRANSMUCOSAL DRUG DELIVERY

7.8.2.2 VAGINAL TRANSMUCOSAL DRUG DELIVERY

7.9 IMPLANTABLE DRUG DELIVERY

7.9.1 PASSIVE IMPLANTABLE DRUG DELIVERY DEVICES

7.9.2 ACTIVE IMPLANTABLE DRUG DELIVERY DEVICES

8 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY END USER

8.1 OVERVIEW

8.2 HOSPITALS

8.3 HOME HEALTHCARE

8.4 CLINICS

8.5 COMMUNITY HEALTHCARE

8.6 OTHERS

9 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL

9.1 OVERVIEW

9.2 DIRECT TENDERS

9.3 HOSPITAL PHARMACIES

9.4 PHARMACY STORES

9.5 ONLINE PHARMACY

10 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY REGION

10.1 ASIA-PACIFIC

10.1.1 JAPAN

10.1.2 CHINA

10.1.3 INDIA

10.1.4 SOUTH KOREA

10.1.5 AUSTRALIA

10.1.6 THAILAND

10.1.7 MALAYSIA

10.1.8 SINGAPORE

10.1.9 INDONESIA

10.1.10 PHILIPPINES

10.1.11 REST OF ASIA-PACIFIC

11 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: COMPANY LANDSCAPE

11.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

12 SWOT ANALYSIS

13 COMPANY PROFILE

13.1 JOHNSON & JOHNSON SERVICES, INC.

13.1.1 COMPANY SNAPSHOT

13.1.2 REVENUE ANALYSIS

13.1.3 COMPANY SHARE ANALYSIS

13.1.4 PRODUCT PORTFOLIO

13.1.5 RECENT DEVELOPMENTS

13.2 NOVARTIS AG

13.2.1 COMPANY SNAPSHOT

13.2.2 REVENUE ANALYSIS

13.2.3 COMPANY SHARE ANALYSIS

13.2.4 PRODUCT PORTFOLIO

13.2.5 RECENT DEVELOPMENTS

13.3 F. HOFFMANN-LA ROCHE LTD

13.3.1 COMPANY SNAPSHOT

13.3.2 REVENUE ANALYSIS

13.3.3 COMPANY SHARE ANALYSIS

13.3.4 PRODUCT PORTFOLIO

13.3.5 RECENT DEVELOPMENT

13.4 BAYER AG

13.4.1 COMPANY SNAPSHOT

13.4.2 REVENUE ANALYSIS

13.4.3 COMPANY SHARE ANALYSIS

13.4.4 PRODUCT PORTFOLIO

13.5 PFIZER INC.

13.5.1 COMPANY SNAPSHOT

13.5.2 REVENUE ANALYSIS

13.5.3 COMPANY SHARE ANALYSIS

13.5.4 PRODUCT PORTFOLIO

13.5.5 RECENT DEVELOPMENT

13.6 3M

13.6.1 COMPANY SNAPSHOT

13.6.2 REVENUE ANALYSIS

13.6.3 PRODUCT PORTFOLIO

13.6.4 RECENT DEVELOPMENTS

13.7 ABBVIE INC.

13.7.1 COMPANY SNAPSHOT

13.7.2 REVENUE ANALYSIS

13.7.3 PRODUCT PORTFOLIO

13.7.4 RECENT DEVELOPMENTS

13.8 AMGEN INC.

13.8.1 COMPANY SNAPSHOT

13.8.2 REVENUE ANALYSIS

13.8.3 PRODUCT PORTFOLIO

13.8.4 RECENT DEVELOPMENTS

13.9 BD

13.9.1 COMPANY SNAPSHOT

13.9.2 REVENUE ANALYSIS

13.9.3 PRODUCT PORTFOLIO

13.9.4 RECENT DEVELOPMENT

13.1 ELCAM MEDICAL

13.10.1 COMPANY SNAPSHOT

13.10.2 PRODUCT PORTFOLIO

13.10.3 RECENT DEVELOPMENT

13.11 ENABLE INJECTIONS

13.11.1 COMPANY SNAPSHOT

13.11.2 PRODUCT PORTFOLIO

13.11.3 RECENT DEVELOPMENTS

13.12 GERRESHEIMER AG

13.12.1 COMPANY SNAPSHOT

13.12.2 REVENUE ANALYSIS

13.12.3 PRODUCT PORTFOLIO

13.12.4 RECENT DEVELOPMENTS

13.13 GSK PLC.

13.13.1 COMPANY SNAPSHOT

13.13.2 REVENUE ANALYSIS

13.13.3 PRODUCT PORTFOLIO

13.13.4 RECENT DEVELOPMENTS

13.14 INSULET CORPORATION

13.14.1 COMPANY SNAPSHOT

13.14.2 REVENUE ANALYSIS

13.14.3 PRODUCT PORTFOLIO

13.14.4 RECENT DEVELOPMENTS

13.15 MEDMIX

13.15.1 COMPANY SNAPSHOT

13.15.2 REVENUE ANALYSIS

13.15.3 PRODUCT PORTFOLIO

13.15.4 RECENT DEVELOPMENTS

13.16 MERCK & CO., INC.

13.16.1 COMPANY SNAPSHOT

13.16.2 REVENUE ANALYSIS

13.16.3 PRODUCT PORTFOLIO

13.16.4 RECENT DEVELOPMENT

13.17 ORASURE TECHNOLOGIES INC.

13.17.1 COMPANY SNAPSHOT

13.17.2 REVENUE ANALYSIS

13.17.3 PRODUCT PORTFOLIO

13.17.4 RECENT DEVELOPMENT

13.18 SANOFI

13.18.1 COMPANY SNAPSHOT

13.18.2 REVENUE ANALYSIS

13.18.3 PRODUCT PORTFOLIO

13.18.4 RECENT DEVELOPMENTS

13.19 SMC LTD.

13.19.1 COMPANY SNAPSHOT

13.19.2 REVENUE ANALYSIS

13.19.3 PRODUCT PORTFOLIO

13.19.4 RECENT DEVELOPMENTS

13.2 VIVO SMART MEDICAL DEVICES LTD.

13.20.1 COMPANY SNAPSHOT

13.20.2 PRODUCT PORTFOLIO

13.20.3 RECENT DEVELOPMENT

13.21 WEST PHARMACEUTICAL SERVICES, INC.

13.21.1 COMPANY SNAPSHOT

13.21.2 REVENUE ANALYSIS

13.21.3 PRODUCT PORTFOLIO

13.21.4 RECENT DEVELOPMENT

14 QUESTIONNAIRE

15 RELATED REPORTS

表格列表

TABLE 1 LIST OF FDA APPROVED BIOLOGICS, IN 2022

TABLE 2 10 MOST EXPENSIVE DRUGS IN THE U.S. (IN USD MILLION)

TABLE 3 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 4 ASIA-PACIFIC ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 5 ASIA-PACIFIC ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 6 ASIA-PACIFIC SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 7 ASIA-PACIFIC LIQUID ORAL DRUG IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 8 ASIA-PACIFIC SEMI SOLID ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 9 ASIA-PACIFIC INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 10 ASIA-PACIFIC INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 11 ASIA-PACIFIC INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 12 ASIA-PACIFIC INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 13 ASIA-PACIFIC CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 14 ASIA-PACIFIC CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE 2022-2031 (USD MILLION)

TABLE 15 ASIA-PACIFIC CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 16 ASIA-PACIFIC SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 17 ASIA-PACIFIC TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 18 ASIA-PACIFIC TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 19 ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 20 ASIA-PACIFIC SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 21 ASIA-PACIFIC LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 22 ASIA-PACIFIC SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 23 ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 24 ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 25 ASIA-PACIFIC OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 26 ASIA-PACIFIC LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 27 ASIA-PACIFIC SEMI SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 28 ASIA-PACIFIC NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 29 ASIA-PACIFIC NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 30 ASIA-PACIFIC PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 31 ASIA-PACIFIC TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 32 ASIA-PACIFIC NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 33 ASIA-PACIFIC TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 34 ASIA-PACIFIC TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 35 ASIA-PACIFIC ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 36 ASIA-PACIFIC OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 37 ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 38 ASIA-PACIFIC TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 39 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 40 ASIA-PACIFIC HOSPITALS IN DRUG DELIVERY MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 41 ASIA-PACIFIC HOME HEALTHCARE IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 42 ASIA-PACIFIC CLINICS IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 43 ASIA-PACIFIC COMMUNITY HEALTHCARE IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 44 ASIA-PACIFIC OTHERS IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 45 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 46 ASIA-PACIFIC DIRECT TENDERS IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 47 ASIA-PACIFIC HOSPITAL PHARMACIES IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 48 ASIA-PACIFIC PHARMACY STORES IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 49 ASIA-PACIFIC ONLINE PHARMACY IN DRUG DELIVERY DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 50 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2022-2031 (USD MILLION)

TABLE 51 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 52 ASIA-PACIFIC ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 53 ASIA-PACIFIC SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 54 ASIA-PACIFIC LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 55 ASIA-PACIFIC SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 56 ASIA-PACIFIC INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 57 ASIA-PACIFIC INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 58 ASIA-PACIFIC INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 59 ASIA-PACIFIC CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 60 ASIA-PACIFIC CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 61 ASIA-PACIFIC CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 62 ASIA-PACIFIC SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 63 ASIA-PACIFIC TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 64 ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 65 ASIA-PACIFIC SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 66 ASIA-PACIFIC LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 67 ASIA-PACIFIC SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 68 ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 69 ASIA-PACIFIC OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 70 ASIA-PACIFIC LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 71 ASIA-PACIFIC SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 72 ASIA-PACIFIC NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 73 ASIA-PACIFIC PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 74 ASIA-PACIFIC NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 75 ASIA-PACIFIC TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 76 ASIA-PACIFIC ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 77 ASIA-PACIFIC OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 78 ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 79 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 80 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 81 JAPAN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 82 JAPAN ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 83 JAPAN SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 84 JAPAN LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 85 JAPAN SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 86 JAPAN INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 87 JAPAN INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 88 JAPAN INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 89 JAPAN CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 90 JAPAN CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 91 JAPAN CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 92 JAPAN SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 93 JAPAN TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 94 JAPAN TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 95 JAPAN SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 96 JAPAN LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 97 JAPAN SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 98 JAPAN OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 99 JAPAN OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 100 JAPAN LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 101 JAPAN SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 102 JAPAN NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 103 JAPAN PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 104 JAPAN NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 105 JAPAN TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 106 JAPAN ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 107 JAPAN OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 108 JAPAN IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 109 JAPAN DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 110 JAPAN DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 111 CHINA DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 112 CHINA ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 113 CHINA SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 114 CHINA LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 115 CHINA SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 116 CHINA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 117 CHINA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 118 CHINA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 119 CHINA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 120 CHINA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 121 CHINA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 122 CHINA SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 123 CHINA TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 124 CHINA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 125 CHINA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 126 CHINA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 127 CHINA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 128 CHINA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 129 CHINA OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 130 CHINA LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 131 CHINA SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 132 CHINA NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 133 CHINA PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 134 CHINA NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 135 CHINA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 136 CHINA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 137 CHINA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 138 CHINA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 139 CHINA DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 140 CHINA DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 141 INDIA DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 142 INDIA ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 143 INDIA SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 144 INDIA LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 145 INDIA SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 146 INDIA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 147 INDIA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 148 INDIA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 149 INDIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 150 INDIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 151 INDIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 152 INDIA SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 153 INDIA TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 154 INDIA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 155 INDIA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 156 INDIA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 157 INDIA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 158 INDIA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 159 INDIA OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 160 INDIA LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 161 INDIA SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 162 INDIA NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 163 INDIA PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 164 INDIA NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 165 INDIA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 166 INDIA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 167 INDIA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 168 INDIA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 169 INDIA DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 170 INDIA DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 171 SOUTH KOREA DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 172 SOUTH KOREA ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 173 SOUTH KOREA SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 174 SOUTH KOREA LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 175 SOUTH KOREA SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 176 SOUTH KOREA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 177 SOUTH KOREA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 178 SOUTH KOREA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 179 SOUTH KOREA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 180 SOUTH KOREA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 181 SOUTH KOREA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 182 SOUTH KOREA SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 183 SOUTH KOREA TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 184 SOUTH KOREA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 185 SOUTH KOREA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 186 SOUTH KOREA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 187 SOUTH KOREA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 188 SOUTH KOREA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 189 SOUTH KOREA OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 190 SOUTH KOREA LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 191 SOUTH KOREA SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 192 SOUTH KOREA NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 193 SOUTH KOREA PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 194 SOUTH KOREA NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 195 SOUTH KOREA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 196 SOUTH KOREA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 197 SOUTH KOREA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 198 SOUTH KOREA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 199 SOUTH KOREA DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 200 SOUTH KOREA DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 201 AUSTRALIA DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 202 AUSTRALIA ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 203 AUSTRALIA SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 204 AUSTRALIA LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 205 AUSTRALIA SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 206 AUSTRALIA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 207 AUSTRALIA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 208 AUSTRALIA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 209 AUSTRALIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 210 AUSTRALIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 211 AUSTRALIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 212 AUSTRALIA SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 213 AUSTRALIA TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 214 AUSTRALIA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 215 AUSTRALIA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 216 AUSTRALIA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 217 AUSTRALIA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 218 AUSTRALIA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 219 AUSTRALIA OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 220 AUSTRALIA LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 221 AUSTRALIA SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 222 AUSTRALIA NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 223 AUSTRALIA PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 224 AUSTRALIA NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 225 AUSTRALIA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 226 AUSTRALIA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 227 AUSTRALIA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 228 AUSTRALIA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 229 AUSTRALIA DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 230 AUSTRALIA DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 231 THAILAND DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 232 THAILAND ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 233 THAILAND SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 234 THAILAND LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 235 THAILAND SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 236 THAILAND INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 237 THAILAND INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 238 THAILAND INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 239 THAILAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 240 THAILAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 241 THAILAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 242 THAILAND SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 243 THAILAND TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 244 THAILAND TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 245 THAILAND SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 246 THAILAND LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 247 THAILAND SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 248 THAILAND OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 249 THAILAND OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 250 THAILAND LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 251 THAILAND SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 252 THAILAND NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 253 THAILAND PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 254 THAILAND NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 255 THAILAND TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 256 THAILAND ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 257 THAILAND OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 258 THAILAND IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 259 THAILAND DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 260 THAILAND DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 261 MALAYSIA DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 262 MALAYSIA ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 263 MALAYSIA SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 264 MALAYSIA LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 265 MALAYSIA SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 266 MALAYSIA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 267 MALAYSIA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 268 MALAYSIA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 269 MALAYSIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 270 MALAYSIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 271 MALAYSIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 272 MALAYSIA SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 273 MALAYSIA TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 274 MALAYSIA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 275 MALAYSIA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 276 MALAYSIA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 277 MALAYSIA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 278 MALAYSIA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 279 MALAYSIA OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 280 MALAYSIA LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 281 MALAYSIA SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 282 MALAYSIA NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 283 MALAYSIA PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 284 MALAYSIA NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 285 MALAYSIA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 286 MALAYSIA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 287 MALAYSIA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 288 MALAYSIA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 289 MALAYSIA DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 290 MALAYSIA DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 291 SINGAPORE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 292 SINGAPORE ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 293 SINGAPORE SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 294 SINGAPORE LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 295 SINGAPORE SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 296 SINGAPORE INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 297 SINGAPORE INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 298 SINGAPORE INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 299 SINGAPORE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 300 SINGAPORE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 301 SINGAPORE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 302 SINGAPORE SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 303 SINGAPORE TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 304 SINGAPORE TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 305 SINGAPORE SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 306 SINGAPORE LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 307 SINGAPORE SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 308 SINGAPORE OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 309 SINGAPORE OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 310 SINGAPORE LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 311 SINGAPORE SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 312 SINGAPORE NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 313 SINGAPORE PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 314 SINGAPORE NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 315 SINGAPORE TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 316 SINGAPORE ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 317 SINGAPORE OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 318 SINGAPORE IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 319 SINGAPORE DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 320 SINGAPORE DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 321 INDONESIA DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 322 INDONESIA ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 323 INDONESIA SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 324 INDONESIA LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 325 INDONESIA SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 326 INDONESIA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 327 INDONESIA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 328 INDONESIA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 329 INDONESIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 330 INDONESIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 331 INDONESIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 332 INDONESIA SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 333 INDONESIA TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 334 INDONESIA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 335 INDONESIA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 336 INDONESIA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 337 INDONESIA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 338 INDONESIA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 339 INDONESIA OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 340 INDONESIA LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 341 INDONESIA SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 342 INDONESIA NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 343 INDONESIA PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 344 INDONESIA NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 345 INDONESIA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 346 INDONESIA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 347 INDONESIA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 348 INDONESIA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 349 INDONESIA DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 350 INDONESIA DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 351 PHILIPPINES DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 352 PHILIPPINES ORAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 353 PHILIPPINES SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 354 PHILIPPINES LIQUID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 355 PHILIPPINES SEMI SOLID ORAL DRUGS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 356 PHILIPPINES INJECTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 357 PHILIPPINES INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 358 PHILIPPINES INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 359 PHILIPPINES CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2022-2031 (USD MILLION)

TABLE 360 PHILIPPINES CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 361 PHILIPPINES CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 362 PHILIPPINES SELF INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2022-2031 (USD MILLION)

TABLE 363 PHILIPPINES TOPICAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 364 PHILIPPINES TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 365 PHILIPPINES SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 366 PHILIPPINES LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 367 PHILIPPINES SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 368 PHILIPPINES OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 369 PHILIPPINES OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY FORM, 2022-2031 (USD MILLION)

TABLE 370 PHILIPPINES LIQUID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 371 PHILIPPINES SEMI-SOLID OCCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 372 PHILIPPINES NASAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 373 PHILIPPINES PULMONARY DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 374 PHILIPPINES NEBULIZERS IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 375 PHILIPPINES TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 376 PHILIPPINES ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 377 PHILIPPINES OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 378 PHILIPPINES IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 379 PHILIPPINES DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 380 PHILIPPINES DRUG DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 381 REST OF ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

图片列表

FIGURE 1 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: SEGMENTATION

FIGURE 2 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: DATA TRIANGULATION

FIGURE 3 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: DROC ANALYSIS

FIGURE 4 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS

FIGURE 5 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: MARKET END USER COVERAGE GRID

FIGURE 8 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: DBMR MARKET POSITION GRID

FIGURE 9 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: SEGMENTATION

FIGURE 11 EXECUTIVE SUMMARY

FIGURE 12 EIGHT SEGMENTS COMPRISE THE ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE

FIGURE 13 STRATEGIC DECISIONS

FIGURE 14 RISING PREVALENCE OF CHRONIC DISEASE AND NON-CHRONIC DISEASE ARE DRIVING THE GROWTH OF THE ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET FROM 2024 TO 2031

FIGURE 15 THE ORAL DRUG DELIVERY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET IN 2024 AND 2031

FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET

FIGURE 17 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: BY PRODUCT TYPE, 2023

FIGURE 18 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: BY PRODUCT TYPE, 2023-2031 (USD MILLION)

FIGURE 19 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: BY PRODUCT TYPE, CAGR (2024-2031)

FIGURE 20 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 21 ASIA-PACIFIC DRUG DELIVERY MARKET: BY END USER, 2023

FIGURE 22 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: BY END USER, 2024-2031 (USD MILLION)

FIGURE 23 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: END USER, CAGR (2024-2031)

FIGURE 24 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: END USER, LIFELINE CURVE

FIGURE 25 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2023

FIGURE 26 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD MILLION)

FIGURE 27 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)

FIGURE 28 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 29 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: SNAPSHOT (2023)

FIGURE 30 ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET: COMPANY SHARE 2023 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on Asia-Pacific Drug Delivery Devices Market, By Product Type (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ophthalmic Drug Delivery, Nasal Drug Delivery, Pulmonary Drug Delivery, Transmucosal Drug Delivery, and Implantable Drug Delivery), End User (Hospitals, Home Healthcare, Clinics, Community Healthcare and Others), Distribution Channel (Direct Tenders, Hospital Pharmacies, Pharmacy Stores, and Online Pharmacy) - Industry Trends and Forecast to 2031. .
The Asia Pacific Apac Drug Delivery Devices Market size was valued at USD 320.82 USD Billion in 2023.
The Asia Pacific Apac Drug Delivery Devices Market is projected to grow at a CAGR of 9.9% during the forecast period of 2024 to 2031.
The major players operating in the market include , F. Hoffmann,La Roche , Mylan N.V. , Teva Pharmaceutical Industries , Sanofi , Pfizer , GlaxoSmithKline plc , Novartis AG , Sun Pharmaceutical Industries , Dr. Reddy's Laboratories , Bausch Health Companies , AstraZeneca , Johnson & Johnson Private Limited , Merck & Co. , Cadila Pharmaceuticals. , 3M , Bayer AG , Astellas Pharma , AbbVie , Takeda Pharmaceutical Company Limited ,.
The market report covers data from the Japan, China, South Korea, India, Singapore, Thailand, Indonesia, Malaysia, Philippines, Australia, and rest of Asia-Pacific.